{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:53:26Z","timestamp":1772916806465,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"crossref","award":["H14-Toxico-001"],"award-info":[{"award-number":["H14-Toxico-001"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"crossref","award":["H19-Toxico-001"],"award-info":[{"award-number":["H19-Toxico-001"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.tox.2012.02.015","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T10:33:13Z","timestamp":1331202793000},"page":"1-7","source":"Crossref","is-referenced-by-count":19,"title":["Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration"],"prefix":"10.1016","volume":"295","author":[{"given":"Henrik T.","family":"Yudate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohsuke","family":"Minowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Urushidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2012.02.015_bib0005","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tox.2012.02.015_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/kfl184","article-title":"Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells","volume":"96","author":"Atienzar","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2012.02.015_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.taap.2006.10.015","article-title":"Biomarkers to monitor drug-induced phospholipidosis","volume":"218","author":"Baronas","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2012.02.015_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/01926230701196414","article-title":"Phospholipidosis in nonclinical toxicity studies","volume":"35","author":"Berridge","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2012.02.015_bib0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2008.09.017","article-title":"Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development","volume":"186","author":"Blomme","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2012.02.015_bib0030","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1002\/sim.2764","article-title":"Age-period-cohort models for the Lexis diagram","volume":"26","author":"Carstensen","year":"2007","journal-title":"Stat. Med."},{"key":"10.1016\/j.tox.2012.02.015_bib0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/clpt.2008.274","article-title":"Data-driven methods to discover molecular determinants of serious adverse drug events","volume":"85","author":"Chiang","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2012.02.015_bib0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/13547500400018570","article-title":"Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model","volume":"9","author":"Delaney","year":"2004","journal-title":"Biomarkers"},{"key":"10.1016\/j.tox.2012.02.015_bib0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J. Health Econ."},{"key":"10.1016\/j.tox.2012.02.015_bib0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.etp.2007.01.004","article-title":"Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development","volume":"58","author":"Fujimura","year":"2007","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2012.02.015_bib0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.tox.2012.02.015_bib0060","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1378\/chest.107.6.1763","article-title":"Fluoxetine hydrochloride (Prozac)-induced pulmonary disease","volume":"107","author":"Gonzalez-Rothi","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.tox.2012.02.015_bib0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2012.02.015_bib0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.taap.2008.01.036","article-title":"Gene expression profiling in rat liver treated with compounds inducing phospholipidosis","volume":"229","author":"Hirode","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2012.02.015_bib0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1289\/ehp.845553","article-title":"Pulmonary and generalized lysosomal storage induced by amphiphilic drugs","volume":"55","author":"Hruban","year":"1984","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2012.02.015_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxsci\/kfj067","article-title":"Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential","volume":"90","author":"Kasahara","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2012.02.015_bib0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/15376510701857262","article-title":"Development of a phospholipidosis database and predictive quantitative structure\u2013activity relationship (QSAR) models","volume":"18","author":"Kruhlak","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.tox.2012.02.015_bib0090","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tiv.2009.09.018","article-title":"Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis","volume":"24","author":"Kuroda","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2012.02.015_bib0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfm157","article-title":"In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies","volume":"99","author":"Nioi","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2012.02.015_bib0100","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/ci6004542","article-title":"Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential","volume":"47","author":"Pelletier","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.tox.2012.02.015_bib0105","first-page":"347","article-title":"Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines","volume":"55","author":"Ploemen","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2012.02.015_bib0110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.tox.2012.02.015_bib0115","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tox.2012.02.015_bib0120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system","volume":"83","author":"Sawada","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2012.02.015_bib0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0031-6989(83)80009-5","article-title":"Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat","volume":"15","author":"Sgaragli","year":"1983","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1016\/j.tox.2012.02.015_bib0130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1016156927420","article-title":"Molecular factors influencing retention on immobilized artificial membranes (IAM) compared to partitioning in liposomes and n-octanol","volume":"19","author":"Taillardat-Bertschinger","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tox.2012.02.015_bib0135","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.lfs.2005.11.010","article-title":"Effect of the difference in vehicles on gene expression in the rat liver\u2014analysis of the control data in the Toxicogenomics Project Database","volume":"78","author":"Takashima","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.tox.2012.02.015_bib0140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/17425251003601961","article-title":"Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities","volume":"6","author":"Tengstrand","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tox.2012.02.015_bib0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2131\/jts.31.315","article-title":"Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential","volume":"31","author":"Tomizawa","year":"2006","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tox.2012.02.015_bib0150","series-title":"Handbook of Toxicogenomics\u2014Strategies and Applications","first-page":"623","article-title":"Toxicogenomics: the Japanese initiative","author":"Urushidani","year":"2005"}],"updated-by":[{"DOI":"10.1016\/j.tox.2012.04.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T00:00:00Z","timestamp":1345075200000}}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X12000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X12000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T02:37:42Z","timestamp":1561430262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X12000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":30,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0300483X12000686"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2012.02.015","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}